Evidence map›Paper›PMID 34969380›Full record

ArticleBiomedical engineering online2021

Evaluating effect of metallic ions on aggregation behavior of β-amyloid peptides by atomic force microscope and surface-enhanced Raman Scattering.

Yang Xie, Lin Yu, Yuna Fu, Heng Sun, Jianhua Wang

Open access · goldAbstract read
In one paragraph

Article in Biomedical engineering online, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Molecular details of aluminium-amyloid β peptide interaction by nuclear magnetic resonance.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2022
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Yang XiePharmaceutical Engineering Center, Chongqing Medical and Pharmaceutical College, Chongqing, 401331, China.
Lin YuKey Laboratory of Biorheological Science and Technology, Ministry of Education, and Institute of Biochemistry and Biophysics, College of Bioengineering, Chongqing University, Chongqing, 400044, China.
Yuna FuKey Laboratory of Biorheological Science and Technology, Ministry of Education, and Institute of Biochemistry and Biophysics, College of Bioengineering, Chongqing University, Chongqing, 400044, China.
Heng SunKey Laboratory of Biorheological Science and Technology, Ministry of Education, and Institute of Biochemistry and Biophysics, College of Bioengineering, Chongqing University, Chongqing, 400044, China.
Jianhua WangKey Laboratory of Biorheological Science and Technology, Ministry of Education, and Institute of Biochemistry and Biophysics, College of Bioengineering, Chongqing University, Chongqing, 400044, China. wjh@cqu.edu.cn.ORCID http://orcid.org/0000-0002-0459-7145
Chongqing University · CN

Funding

Basic Research and Frontier Exploration Project of CSTC cstc2018jcyjAX0758National Key Scientific Instrument and Equipment Development Projects of China 21827812
6 · The paper itself

Abstract

backgroundExcessive aggregation of β-amyloid peptides (Aβ) is regarded as the hallmark of Alzheimer's disease. Exploring the underlying mechanism regulating Aβ aggregation remains challenging and investigating aggregation events of Aβ in the presence and absence of metallic ions at molecular level would be meaningful in elucidating the role of metal cations on interactions between Aβ molecules. In this study, chemical self-assembled monolayer (SAM) method was employed to fabricate monolayer of β-amyloid peptides Aβ42 on gold substrate with a bolaamphiphile named 16-Mercaptohexadecanoic acid (MHA). Firstly, the samples of gold substrate (blank control), the MHA-modified substrate, and the Aβ42-modified substrate were detected by X-ray photoelectron spectroscopy (XPS) to track the self-assembly process. Aggregation behaviors of Aβ42 before and after metallic ions (Zn

resultsThe XPS spectra of binding energy of gold substrate (blank control), the MHA-modified substrate, and the Aβ42-modified substrate are well fitted with the corresponding monolayer's composition, which indicates that Aβ42 monolayer is well formed. The recorded surface morphology of different experimental groups obtained by AFM showed markedly different nanostructures, indicating occurrence of aggregation events between Aβ42 molecules after adding metal ions to the solution. Compared to the control group, the presence of metallic ions resulted in the increased size of surface structures on the observed 3D topography. Besides, the intermolecular rupture force of Aβ42 increased with the addition of metallic ions. Further study by SERS showed that the Raman strength of Aβ42 changes significantly after the metal cation treatment. A considerable part of the amide bonds interacts with metal cations, leading to a structural change, which is characterized by the weakened β-fold Raman peak.

conclusionThe AFM imaging results suggest that aggregation events occurred between Aβ42 molecules with the addition of metal cations. In addition, the results of force tests indicate that the presence of metallic ions could promote adhesion between Aβ42 molecules, which is likely to be the trigger for aggregation behavior of Aβ42. Furthermore, the effect of metallic cations on the conformational change of Aβ42 studied by SERS supported the results obtained by AFM. Taken together, the results showed that the presence of substoichiometric metal cations promotes aggregation behavior between Aβ42 molecules on the substrate at pH 7.4.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesGoldHumansIonsPeptide FragmentsSpectrum Analysis, RamanAmyloid beta-PeptidesGoldIonsPeptide FragmentsAtomic force microscopySelf-assembly monolayersSurface-enhanced Raman Scatteringβ-Amyloid peptides

Identifiers

PMID34969380
PMCPMC8717674
OpenAlexW4200167445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.